{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:55:14Z","timestamp":1786118114242,"version":"build-2736575974"},"reference-count":8,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj-2026-100492","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:10:14Z","timestamp":1786014614000},"page":"e100492","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Tuberculosis treatment support using digital adherence technology"],"prefix":"10.1136","volume":"394","author":[{"given":"Noriah","family":"Maraba","sequence":"first","affiliation":[{"name":"The Aurum Institute, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanyaradzwa","family":"Dube","sequence":"additional","affiliation":[{"name":"The Aurum Institute, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[{"name":"The Aurum Institute, Johannesburg, South Africa"},{"name":"School of Public Health, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2026080608050577000_394.aug06_5.e100492.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2026-100195","article-title":"Evaluation of patient centred digital adherence technology for tuberculosis treatment outcomes: pragmatic randomised controlled trial","volume":"394","author":"Rubinstein","year":"2026","journal-title":"BMJ"},{"key":"2026080608050577000_394.aug06_5.e100492.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102745"},{"key":"2026080608050577000_394.aug06_5.e100492.3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00068-2"},{"key":"2026080608050577000_394.aug06_5.e100492.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02270-5"},{"key":"2026080608050577000_394.aug06_5.e100492.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02847-2"},{"key":"2026080608050577000_394.aug06_5.e100492.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30024-8"},{"key":"2026080608050577000_394.aug06_5.e100492.7","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(24)00429-6"},{"key":"2026080608050577000_394.aug06_5.e100492.8","unstructured":"Rachow A Ivanova O Charalambous S ; TB Sequel consortium . TB Sequel: lung outcomes at month 6 after TB treatment initiation in four African countries. 52nd Union Lung Conference 2021: oral presentation."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2026-100492","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2026-100492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:05:12Z","timestamp":1786028712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2026-100492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":8,"alternative-id":["10.1136\/bmj-2026-100492"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2026-100492","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}